Relative survival following response to 7+3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes:An analysis of four SWOG studies

Here we quantify and compare the absolute and relative overall survival (OS) benefits conveyed by complete remission (CR) in AML and high-risk MDS, and by CR with incomplete count recovery (CRi) in AML and by hematologic improvement (HI) in MDS, following treatment with 7+3 versus azacytidine. We co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leukemia
Main Authors: Othus, Megan, Sekeres, Mikkael A., Nand, Sucha, Garcia-Manero, Guillermo, Appelbaum, Frederick R., Erba, Harry P., Estey, Eli
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6367029/
https://ncbi.nlm.nih.gov/pubmed/30315234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-018-0275-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados